A2 Milk shares: what’s the outlook following China strategy day?

Favourable macro trends – including a growing Chinese middle-class and a more health conscious outlook from consumers both rank as key positives for a2 Milk’s future growth prospects.

As the market mulls the full implications of the Mengniu-backed Bellamy's takeover bid, a number of Australian IMF stocks climbed (then traded flat) in response.

On Monday we saw: BAL-AU skyrocket 55% and Wattle Health Australia Limited rise 12%; BUBS Australia also opened higher.

While a2 Milk Co Ltd (ASX: A2M) also initially soared on this takeover news – rising around 7% on Monday, its share price pulled back sharply during yesterday’s session – closing out the day at A$13.10 per share

This volatility persisted even as a2 Milk unveiled its latest investor Strategy Day presentation – which reiterated the company’s lofty China ambitions.

A2 Milk share price: strategy day in focus

Though nothing fundamentally new was revealed as part of this strategy day – taking place in Shanghai from September 17 to 18 – it has given more ‘colour’ to a2 Milk’s all-important China growth strategy.

The main takeaway: a2 Milk Co Ltd is pursuing the two largest consumer markets in the world – China and the US – which between them have a population of 1,720 million.

Australia’s population by comparison stands at just 25 million.

Broader consumer reach is the name of the game here, with the company interestingly noting that: ‘we have high consumer loyalty, yet relatively low awareness – indicating significant growth opportunity.’

Such comments go far to point out why A2M is aggressively bumping up its marketing spend – anticipating it to hit roughly 12% of revenue in FY20.

To that end, a2 Milk is currently focusing on deepening ‘consumer understanding and engagement’, diversifying the company’s business portfolio, and leveraging technology to innovate rapidly.

This focus, says the company, ‘builds on all that has come before us, but requires stepping up.’

Citi, in a broker note this morning noted that this 'stepping up' is likely to come at a cost: with short-term profitability being sacrificed for near-term top-line growth.

To grow or not to grow?

For investors, growth – and whether or not a company can maintain it – is almost certainly one of the most central questions when stocks trade at high multiples. Even after a2 Milk’s recent downward price action – the company continues to trade at a premium to the broader market: commanding a PE ratio of 36.2, according to the ASX.

Indeed, it was this growth: that came in not-quite-high-enough in FY19 that saw a2 Milk Co Ltd’s shares fall off a cliff during reporting season.

Here, the stock dropped around 14%.

Besides this, and as we previously wrote, a particular concern surrounds FY20 margin guidance – which, according to Morgans – looks to be materially weaker than previously expected.

The corollary here is that it expected that it will be harder (and more expensive for that matter) for a2 Milk to see the kind of revenue growth it did in the past.

Click here to read our full coverage of a2 Milk's FY19 results now.

A changing macro environment

Even as those concerns circle, a growing Chinese middle class, stronger fertility rates and taste changes all have the potential to impact a2 Milk’s growth prospects.

For one, in 2013 the company noted that that the average Chinese woman had her first child at 27. By 2018 that age rose to 30 and by 2028 it’s expected to hit 34.

In addition to this, though a2 Milk has noted that birth rates in China have declined, it may very well be offset by rising fertility rates.

Yet maybe the most important macro trend is the prospect of a wealthier China. Citing research from Euromonitor, a2 Milk notes that the ‘higher income’ and the ‘upper middle’ wealth bands are set to significantly increase in the next decade.

Finally, changing consumer tastes look to be well-backed by these growing wealth bands, as demand for health and wellness products rise in China.

A2 Milk’s share price and its investors have been distinct benefactors of these trends in recent years: as a wealthier middle-class buy up a2 Milk's product at a rapid click.

Tellingly, since April 2015, A2M’s share price has risen over 2,000%.

With these favourable conditions emerging, the question investors will likely now be asking is: can a2 Milk Co Ltd ‘step up’ and take advantage of them?

Only time will tell.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.